fda tirzepatide compounding warning 2024 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our March 10, 2025: Patients transitioning

Bhlandt, S., von Kaisenberg, C

A treatment plan that includes adequate protein intake and resistance exercise is not optional at this stage of life

If the concern is monitoring complexity, propose a coordinated plan: baseline thyroid panel before starting tirzepatide, with scheduled TSH rechecks at week 12 and week 24 sent to both prescribers

Peak Wellness operates with licensed physicians and partners with registered compounding pharmacies

Some links may be affiliate links

Key Takeaways A slew of new studies suggest that semglutide (Ozempic/Wegovy) has benefits for health that extend beyond weight loss Subset analyses of prior trials find the drug can curb deaths from all causes, ease COVID-19 severity and treat heart failure These benefits weren't always the result of weight loss, suggesting other mechanisms may be at work FRIDAY, Aug.30, 2024 (HealthDay News) -- New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways